| 1 | 8698063 | Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance. | Eur J Nucl Med | 1996 May |
4 |
| 2 | 8957492 | Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein. | Surgery | 1996 Dec |
2 |
| 3 | 9472628 | 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein. | Br J Cancer | 1998 |
1 |
| 4 | 9476923 | Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. | J Nucl Med | 1998 Feb |
4 |
| 5 | 9553170 | Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET? | Eur J Nucl Med | 1998 Apr |
4 |
| 6 | 9655294 | Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: relation to patient prognosis and chemotherapy response--a preliminary report. | Cancer | 1998 Jul 1 |
4 |
| 7 | 9669392 | P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. | J Nucl Med | 1998 Jul |
4 |
| 8 | 9712381 | Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging. | Clin Nucl Med | 1998 Aug |
2 |
| 9 | 10551471 | Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma. | Clin Nucl Med | 1999 Nov |
1 |
| 10 | 10572908 | The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy. | Nucl Med Commun | 1999 Nov |
1 |
| 11 | 10779636 | Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results. | Cancer Lett | 2000 May 29 |
3 |
| 12 | 10783567 | [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl]. | Kaku Igaku | 2000 Mar |
1 |
| 13 | 10836685 | Tc-99m MIBI to evaluate children with Ewing's sarcoma. | Clin Nucl Med | 2000 Jun |
1 |
| 14 | 10928145 | Expression of drug resistance protein related to Tc-99m MIBI breast imaging. | Anticancer Res | 2000 May-Jun |
5 |
| 15 | 10994728 | Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines. | J Nucl Med | 2000 Sep |
1 |
| 16 | 11007510 | 99mTc-MIBI radio-guided minimally invasive parathyroid surgery planned on the basis of a preoperative combined 99mTc-pertechnetate/99mTc-MIBI and ultrasound imaging protocol. | Eur J Nucl Med | 2000 Sep |
1 |
| 17 | 11245443 | P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. | Cancer Res | 2001 Feb 15 |
4 |
| 18 | 11337555 | In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line. | J Nucl Med | 2001 Apr |
1 |
| 19 | 11577755 | Usefulness of tc-99m MIBI SPECT in predicting multidrug resistance gene expression levels in non-small cell lung cancer--a preliminary report. | Ann Nucl Med | 2001 Aug |
1 |
| 20 | 11585293 | The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. | Eur J Nucl Med | 2001 Sep |
4 |
| 21 | 11585860 | Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer. | J Nucl Med | 2001 Oct |
4 |
| 22 | 11711312 | Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings. | Nucl Med Biol | 2001 Nov |
1 |
| 23 | 11792039 | The correlation between 99mTc-MIBI uptake and MIB-1 as a nuclear proliferation marker in glioma--a comparative study with 201Tl. | Neuroradiology | 2001 Dec |
2 |
| 24 | 11822755 | Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression. | Ann Oncol | 2001 Nov |
2 |
| 25 | 12002701 | Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging. | Eur J Nucl Med Mol Imaging | 2002 Mar |
1 |
| 26 | 12017298 | MRP1 modulation by PAK-104P: detection with technetium-99m-MIBI in cultured lung tumor cells. | Anticancer Res | 2002 Jan-Feb |
1 |
| 27 | 12029556 | Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients. | Eur J Nucl Med Mol Imaging | 2002 Jun |
5 |
| 28 | 12043903 | The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer. | Ann Nucl Med | 2002 Apr |
8 |
| 29 | 12126530 | [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer]. | Zhonghua Yi Xue Za Zhi | 2002 Jun 25 |
4 |
| 30 | 12173014 | Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression. | Eur J Nucl Med Mol Imaging | 2002 Aug |
1 |
| 31 | 12206484 | Effect of expression of P-glycoprotein on technetium-99m methoxyisobutylisonitrile single photon emission computed tomography of brain tumors. | Neurol Med Chir (Tokyo) | 2002 Aug |
1 |
| 32 | 12453590 | Breast cancer imaging with PET and SPECT agents: an in vivo comparison. | Nucl Med Biol | 2002 Nov |
1 |
| 33 | 12601486 | Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells. | Ann Hematol | 2003 Feb |
7 |
| 34 | 12665314 | Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan. | Endocr Res | 2003 Feb |
2 |
| 35 | 12673168 | Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia. | Nucl Med Commun | 2003 Apr |
1 |
| 36 | 12693711 | Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes. | Gen Physiol Biophys | 2002 Dec |
1 |
| 37 | 12721767 | Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma. | Eur J Nucl Med Mol Imaging | 2003 Jun |
1 |
| 38 | 12769210 | Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. | Am Surg | 2003 May |
1 |
| 39 | 12963129 | Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer. | Cancer Lett | 2003 Sep 10 |
6 |
| 40 | 14514974 | Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer. | Med Oncol | 2003 |
2 |
| 41 | 14666386 | Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines. | Eur J Nucl Med Mol Imaging | 2004 Apr |
2 |
| 42 | 14979918 | Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer. | Breast Cancer Res | 2004 |
5 |
| 43 | 15011866 | Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression. | Hepatogastroenterology | 2004 Jan-Feb |
3 |
| 44 | 15450141 | Impaired Tc-99m MIBI uptake in the thyroid and parathyroid glands during early phase imaging in hemodialysis patients. | Rev Esp Med Nucl | 2004 Sep-Oct |
1 |
| 45 | 15545562 | Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. | Arch Surg | 2004 Nov |
5 |
| 46 | 15637529 | Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. | Clin Pharmacol Ther | 2005 Jan |
3 |
| 47 | 15902437 | To use MIBI or not to use MIBI? That is the question when assessing tumour cells. | Eur J Nucl Med Mol Imaging | 2005 Jul |
3 |
| 48 | 15956063 | MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients. | Nephrol Dial Transplant | 2005 Sep |
1 |
| 49 | 16026704 | Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin. | Nucl Med Biol | 2005 Aug |
3 |
| 50 | 16150247 | Radionuclide imaging of the parathyroid glands. | Semin Nucl Med | 2005 Oct |
2 |